Alerts will be sent to your verified email
Verify Email
ONESOURCE
|
Onesource Specialty
|
Astrazeneca Pharma I
|
Pfizer
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
-74.5 % | 17.42 % | 19.03 % |
|
5yr average Equity Multiplier
|
2.76 | 1.99 | 1.25 |
|
5yr Average Asset Turnover Ratio
|
0.07 | 0.91 | 0.6 |
|
5yr Avg Net Profit Margin
|
-824.62 % | 9.65 % | 26.04 % |
|
Price to Book
|
3.6 | 28.86 | 5.48 |
|
P/E
|
0.0 | 192.09 | 30.1 |
|
5yr Avg Cash Conversion Cycle
|
-239.17 Days | -6.33 Days | 21.86 Days |
|
Inventory Days
|
954.68 Days | 68.19 Days | 49.93 Days |
|
Days Receivable
|
62.7 Days | 35.81 Days | 29.1 Days |
|
Days Payable
|
620.72 Days | 187.52 Days | 77.28 Days |
|
5yr Average Interest Coverage Ratio
|
-3.99 | 142.38 | 185.18 |
|
5yr Avg ROCE
|
-15.49 % | 23.84 % | 23.84 % |
|
5yr Avg Operating Profit Margin
|
-156.51 % | 14.57 % | 31.72 % |
|
5 yr average Debt to Equity
|
1.21 | 0.0 | 0.0 |
|
5yr CAGR Net Profit
|
11.09 % | 4.4 % | 76.68 % |
|
5yr Average Return on Assets
|
-26.39 % | 8.92 % | 15.25 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
29.79 % | 75.0 % | 63.92 % |
|
Share Pledged by Promoters
|
25.01 % | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
-7.98 % | 0.0 | 0.0 |
|
Change in Mutual Fund Holding (3 Yrs)
|
4.44 % | 3.26 % | 4.53 % |
|
Onesource Specialty
|
Astrazeneca Pharma I
|
Pfizer
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|